Federal Register / Vol. 83, No. 147 / Tuesday, July 31, 2018 / Notices 36935 

this second notice to request comments 

regarding the following: (1) Whether the 

collection of information is necessary 

for the proper performance of FHFA 

functions, including whether the 

information has practical utility; (2) the 

accuracy of FHFA’s estimates of the 

burdens of the collection of information; 

(3) ways to enhance the quality, utility, 

and clarity of the information collected; 

and (4) ways to minimize the burden of 

the collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Dated: July 26, 2018. 

Kevin Winkler, 

Chief Information Officer, Federal Housing 

Finance Agency. 

[FR Doc. 2018–16350 Filed 7–30–18; 8:45 am] 

BILLING CODE 8070–01–P 

FEDERAL MARITIME COMMISSION 

Notice of Agreement Filed 

The Commission hereby gives notice 

of the filing of the following agreement 

under the Shipping Act of 1984. 

Interested parties may submit comments 

on the agreement to the Secretary by 

email at Secretary@fmc.gov, or by mail, 

Federal Maritime Commission, 

Washington, DC 20573, within twelve 

days of the date this notice appears in 

the Federal Register. Copies of the 

agreement are available through the 

Commission’s website (www.fmc.gov) or 

by contacting the Office of Agreements 

at (202)-523–5793 or tradeanalysis@

fmc.gov. 

Agreement No.: 201263. 

Agreement Name: Maersk/MSC/Zim 

Cooperative Working Agreement. 

Parties: Maersk Line A/S; 

Mediterranean Shipping Company S.A.; 

and Zim Integrated Shipping Services 

Ltd. 

Filing Party: Wayne Rohde, Cozen 

O’Connor. 

Synopsis: The Agreement authorizes 

the parties to share space and cooperate 

on the provision of service strings in the 

trade between Asia and the U.S. East 

Coast. 

Proposed Effective Date: 9/8/2018. 

Location: https://www2.fmc.gov/ 

FMC.Agreements.Web/Public/ 

AgreementHistory/14256. 

Dated: July 25, 2018. 

Rachel Dickon, 

Secretary. 

[FR Doc. 2018–16280 Filed 7–30–18; 8:45 am] 

BILLING CODE P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The applications will also be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than August 23, 

2018. 

A. Federal Reserve Bank of 

Minneapolis (Mark A. Rauzi, Vice 

President), 90 Hennepin Avenue, 

Minneapolis, Minnesota 55480–0291: 

1. Mackinac Financial Corporation, 

Manistique, Michigan; to acquire 100 

percent of the voting shares of Lincoln 

Community Bank, Merrill, Wisconsin. 

Board of Governors of the Federal Reserve 

System, July 26, 2018. 

Yao-Chin Chao, 

Assistant Secretary of the Board. 

[FR Doc. 2018–16337 Filed 7–30–18; 8:45 am] 

BILLING CODE P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The applications will also be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than August 24, 

2018. 

A. Federal Reserve Bank of 

Minneapolis (Mark A. Rauzi, Vice 

President), 90 Hennepin Avenue, 

Minneapolis, Minnesota 55480–0291: 

1. Citizens Community Bancorp, Inc., 

Eau Claire, Wisconsin; to acquire 100 

percent of United Bank, Osseo, 

Wisconsin. 

B. Federal Reserve Bank of St. Louis 

(David L. Hubbard, Senior Manager), 

P.O. Box 442, St. Louis, Missouri 

63166–2034. Comments can also be sent 

electronically to 

Comments.applications@stls.frb.org: 

1. Old National Bancorp, Evansville, 

Indiana; to merge with Klein Financial, 

Inc., Chaska, Minnesota, and thereby 

indirectly acquire KleinBank, also of 

Chaska, Minnesota. 

Board of Governors of the Federal Reserve 

System, July 25, 2018. 

Yao-Chin Chao, 

Assistant Secretary of the Board. 

[FR Doc. 2018–16377 Filed 7–30–18; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RESERVE SYSTEM 

Agency Information Collection 

Activities; Announcement of Board 

Approval Under Delegated Authority 

and Submission to OMB 

AGENCY: Board of Governors of the 

Federal Reserve System. 


daltland on DSKBBV9HB2PROD with NOTICES
36936 Federal Register / Vol. 83, No. 147 / Tuesday, July 31, 2018 / Notices 

SUMMARY: The Board of Governors of the 

Federal Reserve System (Board) is 

adopting a proposal to extend for three 

years, with revision, the Financial 

Statements for Holding Companies (FR 

Y–9 family of reports) (OMB No. 7100– 

0128). 

FOR FURTHER INFORMATION CONTACT: 

Federal Reserve Board Clearance 

Officer—Nuha Elmaghrabi—Office of 

the Chief Data Officer, Board of 

Governors of the Federal Reserve 

System, Washington, DC 20551, (202) 

452–3829. Telecommunications Device 

for the Deaf (TDD) users may contact 

(202) 263–4869, Board of Governors of 

the Federal Reserve System, 

Washington, DC 20551. 

OMB Desk Officer—Shagufta 

Ahmed—Office of Information and 

Regulatory Affairs, Office of 

Management and Budget, New 

Executive Office Building, Room 10235, 

725 17th Street NW, Washington, DC 

20503 or by fax to (202) 395–6974. 

SUPPLEMENTARY INFORMATION: On June 

15, 1984, the Office of Management and 

Budget (OMB) delegated to the Board 

authority under the Paperwork 

Reduction Act (PRA) to approve and 

assign OMB control numbers to 

collection of information requests and 

requirements conducted or sponsored 

by the Board. Board-approved 

collections of information are 

incorporated into the official OMB 

inventory of currently approved 

collections of information. Copies of the 

Paperwork Reduction Act Submission, 

supporting statements and approved 

collection of information instrument(s) 

are placed into OMB’s public docket 

files. The Federal Reserve may not 

conduct or sponsor, and the respondent 

is not required to respond to, an 

information collection that has been 

extended, revised, or implemented on or 

after October 1, 1995, unless it displays 

a currently valid OMB control number. 

Final approval under OMB delegated 

authority the extension for three years, 

with revision, of the following reports: 

Report title: Financial Statements for 

Holding Companies. 

Agency form number: FR Y–9C, FR 

Y–9LP, FR Y–9SP, FR Y–9ES, and FR 

Y–9CS. 

OMB control number: 7100–0128. 

Effective Date: June 30, 2018. 

Frequency: Quarterly and 

semiannually. 

Respondents: Bank holding 

companies, savings and loan holding 

companies, securities holding 

companies, and U.S. intermediate 

holding companies (collectively, 

holding companies (HCs)). 

Estimated number of respondents: FR 

Y–9C (non-advanced approaches 

holding companies): 638; FR Y–9C 

(advanced approaches holding 

companies): 18; FR Y–9LP: 775; FR 

Y–9SP: 3,837 FR Y–9ES: 82; FR Y–9CS: 

236. 

Estimated average hours per response: 

FR Y–9C (non-advanced approaches 

holding companies): 46.29 hours; FR 

Y–9C (advanced approaches holding 

companies HCs): 47.54 hours; FR 

Y–9LP: 5.27 hours; FR Y–9SP: 5.40 

hours; FR Y–9ES: 0.50 hours; FR Y–9CS: 

0.50 hours. 

Estimated annual burden hours: FR 

Y–9C (non-advanced approaches 

holding companies): 118,132 hours; FR 

Y–9C (advanced approaches holding 

companies): 3,423 hours; FR Y–9LP: 

16,337 hours; FR Y–9SP:41,440 hours; 

FR Y–9ES: 41 hours; FR Y–9CS: 472 

hours. 

General description of report: The FR 

Y–9C, FR Y–9LP, and FR Y 9SP serve 

as standardized financial statements for 

the consolidated holding company. The 

FR Y–9ES is a financial statement for 

HCs that are Employee Stock Ownership 

Plans. The Board uses the FR Y–9CS (a 

free-form supplement) to collect 

additional information deemed to be 

critical and needed in an expedited 

manner. The FR Y–9 family of reporting 

forms continues to be the primary 

source of financial data on HCs that 

examiners rely on between on-site 

inspections. Financial data from these 

reporting forms is used to detect 

emerging financial problems, review 

performance, conduct pre-inspection 

analysis, monitor and evaluate capital 

adequacy, evaluate HC mergers and 

acquisitions, and analyze an HC’s 

overall financial condition to ensure the 

safety and soundness of its operations. 

The Board requires HCs to provide 

standardized financial statements to 

fulfill the Board’s statutory obligation to 

supervise these organizations. HCs file 

the FRY–9C on a quarterly basis, the FR 

Y–9LP quarterly, the FR Y–9SP 

semiannually, the FR Y–9ES annually, 

and the FR Y–9CS on a schedule that is 

determined when this supplement is 

used. 

Legal authorization and 

confidentiality: The FR Y–9 family of 

reports is authorized by section 5(c) of 

the Bank Holding Company Act (12 

U.S.C. 1844(c)), section 10 of Home 

Owners’ Loan Act (12 U.S.C. 1467a(b)), 

section 618 of the Dodd-Frank Wall 

Street Reform and Consumer Protection 

Act (‘‘Dodd-Frank Act’’) (12 U.S.C. 

1850a(c)(1)), and section 165 of the 

Dodd-Frank Act (12 U.S.C. 5365). The 

obligation of covered institutions to 

report this information is mandatory. 

With respect to the FR Y–9LP, FR 

Y–9SP, FR Y–9ES, and FR Y–9CS, as 

well as most items on the FR Y–9C, the 

information collected would generally 

not be accorded confidential treatment. 

If confidential treatment is requested by 

a respondent, the Board will review the 

request to determine if confidential 

treatment is appropriate. With respect to 

the FR Y–9C, Schedule HI’s item 7(g) 

‘‘FDIC deposit insurance assessments,’’ 

Schedule HC–P’s item 7(a) 

‘‘Representation and warranty reserves 

for 1–4 family residential mortgage 

loans sold to U.S. government agencies 

and government sponsored agencies,’’ 

and Schedule HC–P’s item 7(b) 

‘‘Representation and warranty reserves 

for 1–4 family residential mortgage 

loans sold to other parties’’ are 

considered confidential. Such treatment 

is appropriate because the data is not 

publicly available and could cause 

substantial harm to the competitive 

position of the respondent. The public 

release of this confidential data may 

impair the Board’s future ability to 

collect similarly confidential data. Thus, 

this information may be kept 

confidential under exemptions (b)(4) of 

the Freedom of Information Act, which 

exempts from disclosure ‘‘trade secrets 

and commercial or financial information 

obtained from a person [that is] 

privileged or confidential’’ (5 U.S.C. 

552(b)(4)), and (b)(8) of the Freedom of 

Information Act, which exempts from 

disclosure information related to 

examination, operating, or condition 

reports prepared by, on behalf of, or for 

the use of an agency responsible for the 

regulation or supervision of financial 

institutions (5 U.S.C. 552(b)(8)). If 

confidential treatment is requested by a 

respondent for other items in the FR 

Y–9C, the Board will review the request 

to determine if confidential treatment is 

appropriate. 

Current Actions: On April 30, 2018, 

the Board published a notice in the 

Federal Register (83 FR 18843) 

requesting public comment for 60 days 

on the extension, with revision, of the 

FR Y–9C report, and the extension, 

without revision, of the FR Y–9LP, FR 

Y–9SP, FR Y–9ES, and FR Y–9CS 

report. The Board proposed to 

implement a number of revisions to the 

FR Y–9C requirements, most of which 

were consistent with changes now 

implemented on the Federal Financial 

Institutions Examination Council 

(FFIEC) Consolidated Reports of 

Condition and Income (Call Reports) 

(FFIEC 031, FFIEC 041, and FFIEC 051; 

OMB No. 7100–0036). The proposed 

revisions included deleting certain data 

items and consolidating existing data 

items into new data items, as well as 

adding new or raising existing reporting 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 147 / Tuesday, July 31, 2018 / Notices 36937 

thresholds for certain data items to 

reduce reporting burden. The comment 

period expired June 29, 2018. 

Detailed Discussion of Public 

Comments 

The Federal Reserve received one 

comment from a banking association. 

The commenter noted several 

inconsistencies on the FR Y–9C report 

form and one inconsistency on the 

instructions when compared to the Call 

Report pertaining to Schedule HC–Q 

Memoranda items 4.b and 4.d, column 

A and Schedule HC–S Column G 

instructions and requested clarification 

on the proper reporting. The draft report 

form was inadvertently updated to 

reflect the removal of items 4.b and 4.d 

and a line item reference on the 

instructions for Schedule HC–S Column 

G was also inadvertently struck through. 

The Board has revised these items so 

that both the report form and 

instructions align with the Call Report. 

Additionally, the commenter noted an 

inconsistency between the caption on 

the report form and the caption on the 

instructions pertaining to Equity 

investments without readily 

determinable fair values on Schedule 

HC–F line item 4 on the FR Y–9C report. 

The Board has updated the instructions 

so that the report form and instructions 

align. 

The revisions will be implemented as 

proposed, with the modifications 

described above, effective for the June 

30, 2018, report date. 

Board of Governors of the Federal Reserve 

System, July 25, 2018. 

Michele Taylor Fennell, 

Assistant Secretary of the Board. 

[FR Doc. 2018–16265 Filed 7–30–18; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Patient Safety Organizations: 

Voluntary Relinquishment From 

Diagnostic Quality Assurance 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), Department of 

Health and Human Services (HHS). 

ACTION: Notice of delisting. 

SUMMARY: The Patient Safety Rule 

authorizes AHRQ, on behalf of the 

Secretary of HHS, to list as a PSO an 

entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ by 

the Secretary if it is found to no longer 

meet the requirements of the Patient 

Safety Act and Patient Safety Rule, 

when a PSO chooses to voluntarily 

relinquish its status as a PSO for any 

reason, or when a PSO’s listing expires. 

AHRQ has accepted a notification of 

voluntary relinquishment from 

Diagnostic Quality Assurance of its 

status as a PSO, and has delisted the 

PSO accordingly. Diagnostic Quality 

Assurance, PSO number P0170, 

submitted this request for voluntary 

relinquishment after receiving a Notice 

of Preliminary Finding of Deficiency. 

DATES: The directories for both listed 

and delisted PSOs are ongoing and 

reviewed weekly by AHRQ. The 

delisting was effective at 12:00 Midnight 

ET (2400) on July 1, 2018. 

ADDRESSES: Both directories can be 

accessed electronically at the following 

HHS website: http://www.pso.ahrq.gov/ 

listed. 

FOR FURTHER INFORMATION CONTACT: 

Eileen Hogan, Center for Quality 

Improvement and Patient Safety, AHRQ, 

5600 Fishers Lane, Room 06N94B, 

Rockville, MD 20857; Telephone (toll 

free): (866) 403–3697; Telephone (local): 

(301) 427–1111; TTY (toll free): (866) 

438–7231; TTY (local): (301) 427–1130; 

Email: pso@ahrq.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Patient Safety and Quality 

Improvement Act of 2005, 42 U.S.C. 

299b–21 to b–26, (Patient Safety Act) 

and the related Patient Safety and 

Quality Improvement Final Rule, 42 

CFR part 3 (Patient Safety Rule), 

published in the Federal Register on 

November 21, 2008, 73 FR 70732– 

70814, establish a framework by which 

hospitals, doctors, and other health care 

providers may voluntarily report 

information to Patient Safety 

Organizations (PSOs), on a privileged 

and confidential basis, for the 

aggregation and analysis of patient 

safety events. 

The Patient Safety Act authorizes the 

listing of PSOs, which are entities or 

component organizations whose 

mission and primary activity are to 

conduct activities to improve patient 

safety and the quality of health care 

delivery. 

HHS issued the Patient Safety Rule to 

implement the Patient Safety Act. 

AHRQ administers the provisions of the 

Patient Safety Act and Patient Safety 

Rule relating to the listing and operation 

of PSOs. The Patient Safety Rule 

authorizes AHRQ to list as a PSO an 

entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ if 

it is found to no longer meet the 

requirements of the Patient Safety Act 

and Patient Safety Rule, when a PSO 

chooses to voluntarily relinquish its 

status as a PSO for any reason, or when 

a PSO’s listing expires. Section 3.108(d) 

of the Patient Safety Rule requires 

AHRQ to provide public notice when it 

removes an organization from the list of 

federally approved PSOs. 

AHRQ has accepted a notification 

from Diagnostic Quality Assurance, a 

component entity of Quality Star, LLC, 

to voluntarily relinquish its status as a 

PSO. Accordingly, Diagnostic Quality 

Assurance was delisted effective at 

12:00 Midnight ET (2400) on July 1, 

2018. AHRQ notes that that Diagnostic 

Quality Assurance submitted this 

request for voluntary relinquishment 

following receipt of the Notice of 

Preliminary Finding of Deficiency sent 

on April 10, 2018. 

More information on PSOs can be 

obtained through AHRQ’s PSO website 

at http://www.pso.ahrq.gov. 

Francis D. Chesley, Jr., 

Acting Deputy Director. 

[FR Doc. 2018–16327 Filed 7–30–18; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2017–N–0007] 

Biosimilar User Fee Rates for Fiscal 

Year 2019 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

rates for biosimilar user fees for fiscal 

year (FY) 2019. The Federal Food, Drug, 

and Cosmetic Act (FD&C Act), as 

amended by the Biosimilar User Fee 

Amendments of 2017 (BsUFA II), 

authorizes FDA to assess and collect 

user fees for certain activities in 

connection with biosimilar biological 

product development; review of certain 

applications for approval of biosimilar 

biological products; and each biosimilar 

biological product approved in a 

biosimilar biological product 

application. 

BsUFA II directs FDA to establish, 

before the beginning of each fiscal year, 

the amount of initial and annual 

biosimilar biological product 

development (BPD) fees, the 

reactivation fee, and the biosimilar 

biological product application and 


daltland on DSKBBV9HB2PROD with NOTICES